Advances in therapy
Economic Burden of Primary Biliary Cholangitis by Line of Therapy in the United States.
Sonal Kumar, Nisreen Shamseddine, Hongbo Yang, Su Zhang, Dongni Ye, Shravanthi Seshasayee, Jingyi Chen, Kris V Kowdley
Published: 202510.1007/s12325-025-03439-6
Abstract
INTRODUCTION: Lack of or delayed treatment of primary biliary cholangitis (PBC) is associated with worsening outcomes. This study assessed the real-world healthcare resource use (HRU) and costs of PBC in the USA to understand its economic burden by l…
Preview only. Read the full abstract at the source